Vaxart Inc (VXRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 28,700 | 7,379 | 107 | 892 | 4,046 |
| Gross Profit | 28,700 | 7,379 | 107 | 892 | 4,046 |
| Operating Expenses | 94,993 | 90,726 | 114,694 | 73,644 | 34,216 |
| Operating Income | -66,293 | -83,347 | -114,587 | -72,752 | -30,170 |
| Interest Expense | 2,969 | 1,447 | 1,305 | 1,480 | 1,874 |
| Other Income | 2,574 | 2,590 | 8,201 | 3,869 | 62 |
| Pre-tax Income | -66,688 | -82,204 | -107,691 | -70,363 | -31,982 |
| Income Tax | 260 | 261 | 67 | 107 | 238 |
| Net Income Continuous | -66,948 | -82,465 | -107,758 | -70,470 | -32,220 |
| Net Income | $-66,948 | $-82,465 | $-107,758 | $-70,470 | $-32,220 |
| EPS Basic Total Ops | -0.33 | -0.57 | -0.84 | -0.58 | -0.36 |
| EPS Basic Continuous Ops | -0.33 | -0.57 | -0.84 | -0.58 | -0.36 |
| EPS Diluted Total Ops | -0.33 | -0.57 | -0.84 | -0.58 | -0.36 |
| EPS Diluted Continuous Ops | -0.33 | -0.57 | -0.84 | -0.58 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.57 | -0.84 | -0.58 | -0.36 |
| EBITDA(a) | $-58,204 | $-75,382 | $-108,945 | $-68,459 | $-27,460 |